全文获取类型
收费全文 | 407276篇 |
免费 | 27266篇 |
国内免费 | 4950篇 |
专业分类
耳鼻咽喉 | 5457篇 |
儿科学 | 8598篇 |
妇产科学 | 10445篇 |
基础医学 | 56304篇 |
口腔科学 | 12263篇 |
临床医学 | 33981篇 |
内科学 | 81883篇 |
皮肤病学 | 8766篇 |
神经病学 | 28706篇 |
特种医学 | 14898篇 |
外国民族医学 | 105篇 |
外科学 | 63268篇 |
综合类 | 15207篇 |
一般理论 | 66篇 |
预防医学 | 18981篇 |
眼科学 | 10597篇 |
药学 | 34424篇 |
18篇 | |
中国医学 | 4074篇 |
肿瘤学 | 31451篇 |
出版年
2021年 | 3689篇 |
2020年 | 3119篇 |
2019年 | 4276篇 |
2018年 | 5270篇 |
2017年 | 4435篇 |
2016年 | 4285篇 |
2015年 | 5387篇 |
2014年 | 7433篇 |
2013年 | 8773篇 |
2012年 | 12163篇 |
2011年 | 12552篇 |
2010年 | 7624篇 |
2009年 | 6963篇 |
2008年 | 10936篇 |
2007年 | 11741篇 |
2006年 | 11713篇 |
2005年 | 11016篇 |
2004年 | 9725篇 |
2003年 | 9314篇 |
2002年 | 8918篇 |
2001年 | 28825篇 |
2000年 | 29323篇 |
1999年 | 24290篇 |
1998年 | 5514篇 |
1997年 | 4577篇 |
1996年 | 4061篇 |
1995年 | 3830篇 |
1994年 | 3396篇 |
1993年 | 3047篇 |
1992年 | 16233篇 |
1991年 | 14982篇 |
1990年 | 14299篇 |
1989年 | 14062篇 |
1988年 | 12693篇 |
1987年 | 12136篇 |
1986年 | 11175篇 |
1985年 | 10374篇 |
1984年 | 6931篇 |
1983年 | 5610篇 |
1982年 | 2721篇 |
1979年 | 5482篇 |
1978年 | 3345篇 |
1977年 | 2963篇 |
1975年 | 2632篇 |
1974年 | 3062篇 |
1973年 | 2862篇 |
1972年 | 2823篇 |
1971年 | 2763篇 |
1970年 | 2507篇 |
1969年 | 2540篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Psychological mobile app for patients with acute myeloid leukemia: A pilot randomized clinical trial
Areej El-Jawahri MD Marlise R. Luskin MD Joseph A. Greer PhD Lara Traeger PhD Mitchell Lavoie BS Dagny Marie Vaughn BS Stephanie Andrews BS Daniel Yang BS Kofi Y. Boateng BS Richard A. Newcomb MD Nneka N. Ufere MD Amir T. Fathi MD Gabriela Hobbs MD Andrew Brunner MD Gregory A. Abel MD Richard M. Stone MD Daniel J. DeAngelo MD PhD Martha Wadleigh MD Jennifer S. Temel MD 《Cancer》2023,129(7):1075-1084
3.
4.
Thomas Boerner Rebecca A. Carr Meier Hsu Alexa Michel Kay See Tan Elvira Vos Smita Sihag Manjit S. Bains Geoffrey Y. Ku Abraham J. Wu David R. Jones Daniela Molena 《International journal of cancer. Journal international du cancer》2023,152(10):2109-2122
Up to 50% of patients treated with curative esophagectomy for esophageal cancer will develop recurrence, contributing to the dismal survival associated with this disease. Regional recurrence may represent disease that is not yet widely metastatic and may therefore be amenable to more-aggressive treatment. We sought to assess all patients treated with curative esophagectomy for esophageal cancer who developed regional recurrence. We retrospectively identified all patients who underwent esophagectomy for esophageal adenocarcinoma and esophageal squamous cell carcinoma at a single institution from January 2000 to August 2019. In total, 1626 patients were included in the study cohort. As of June 2022, 595 patients had disease recurrence, which was distant or systemic in 435 patients (27%), regional in 125 (7.7%) and local in 35 (2.2%). On multivariable analysis, neoadjuvant chemoradiation with a total radiation dose <45 Gy (hazard ratio [HR], 3.5 [95% CI, 1.7-7.3]; P = .001), pathologic node-positive disease (HR, 1.9 [95% CI, 1.3-3.0]; P = .003) and lymphovascular invasion (HR, 1.6 [95% CI, 1.0-2.5]; P = .049) were predictors of isolated nodal recurrence, whereas increasing age (HR, 0.97 [95% CI, 0.96-0.99]; P = .001) and increasing number of excised lymph nodes (HR, 0.98 [95% CI, 0.95-1.00]; P = .021) were independently associated with decreased risk of regional recurrence. Patients treated with a combination of local and systemic therapies had better survival outcomes than patients treated with systemic therapy alone (P < .001). In patients with recurrence of esophageal cancer limited to regional lymph nodes, salvage treatment may be possible. Higher radiation doses and more-extensive lymphadenectomy may reduce the risk of regional recurrence. 相似文献
5.
Alan G. Nyitray Jenna Nitkowski Timothy L. McAuliffe Bridgett Brzezinski Michael D. Swartz María E. Fernandez Ashish A. Deshmukh Timothy J. Ridolfi Sarah J. Lundeen Leslie Cockerham Dave Wenten Andrew Petroll Brian Hilgeman Jennifer S. Smith Elizabeth Y. Chiao Anna R. Giuliano Vanessa Schick The Prevent Anal Cancer Self-Swab Study Team 《International journal of cancer. Journal international du cancer》2023,153(4):843-853
Sexual minority men are at increased risk for anal squamous cell carcinoma. Our objective was to compare screening engagement among individuals randomized to self-collect an anal canal specimen at home or to attend a clinic appointment. Specimen adequacy was then assessed for human papillomavirus (HPV) DNA genotyping. A randomized trial recruited cisgendered sexual minority men and transgender people in the community and assigned them to use a home-based self-collection swabbing kit or attend a clinic-based swabbing. Swabs were sent for HPV genotyping. The proportions of participants completing screening in each study arm and the adequacy of their specimens for HPV genotyping were assessed. Relative risks were estimated for factors associated with screening. A total of 240 individuals were randomized. Age (median, 46 years) and HIV status (27.1% living with HIV) did not differ by study arm. A total of 89.2% and 74.2% of home-arm and clinic-arm individuals returned the swab, respectively (P = .003), difference between groups, 15.0% (95% CI 5.4%-24.6%). Among black individuals, 96.2% and 63.2% in the home and clinic arms screened (P = .006). Among individuals with HIV, 89.5% and 51.9% in the home and clinic arms screened (P < .001). Self-collected swabs and clinician-collected swabs were comparable in adequacy for HPV genotyping (96.3% and 93.3%, respectively). People at highest risk for anal cancer may be more likely to screen if they are able to self-collect swabs at home rather than attend a clinic. 相似文献
6.
Laurien J. Zeverijn Eleonora J. Looze Subotheni Thavaneswaran J. Maxime van Berge Henegouwen Robert J. Simes Louisa R. Hoes Katrin M. Sjoquist Hanneke van der Wijngaart Lucille Sebastian Birgit S. Geurts Chee K. Lee Gijsbrecht F. de Wit David Espinoza Paul Roepman Frank P. Lin Anne M. L. Jansen Wendy W. J. de Leng Vincent van der Noort Lindsay V. M. Leek Filip Y. F. L. de Vos Carla M. L. van Herpen Hans Gelderblom Henk M. W. Verheul David M. Thomas Emile E. Voest 《International journal of cancer. Journal international du cancer》2023,153(7):1413-1422
The Dutch Drug Rediscovery Protocol (DRUP) and the Australian Cancer Molecular Screening and Therapeutic (MoST) Program are similar nonrandomized, multidrug, pan-cancer trial platforms that aim to identify signals of clinical activity of molecularly matched targeted therapies or immunotherapies outside their approved indications. Here, we report results for advanced or metastatic cancer patients with tumors harboring cyclin D-CDK4/6 pathway alterations treated with CDK4/6 inhibitors palbociclib or ribociclib. We included adult patients that had therapy-refractory solid malignancies with the following alterations: amplifications of CDK4, CDK6, CCND1, CCND2 or CCND3, or complete loss of CDKN2A or SMARCA4. Within MoST, all patients were treated with palbociclib, whereas in DRUP, palbociclib and ribociclib were assigned to different cohorts (defined by tumor type and alteration). The primary endpoint for this combined analysis was clinical benefit, defined as confirmed objective response or stable disease ≥16 weeks. We treated 139 patients with a broad variety of tumor types; 116 with palbociclib and 23 with ribociclib. In 112 evaluable patients, the objective response rate was 0% and clinical benefit rate at 16 weeks was 15%. Median progression-free survival was 4 months (95% CI: 3-5 months), and median overall survival 5 months (95% CI: 4-6 months). In conclusion, only limited clinical activity of palbociclib and ribociclib monotherapy in patients with pretreated cancers harboring cyclin D-CDK4/6 pathway alterations was observed. Our findings indicate that monotherapy use of palbociclib or ribociclib is not recommended and that merging data of two similar precision oncology trials is feasible. 相似文献
7.
8.
9.
Post-induction hypotension is common and associated with postoperative complications. We hypothesised that pneumatic leg compression reduces post-induction hypotension in elderly patients undergoing robot-assisted laparoscopic prostatectomy. In this double-blind randomised study, patients were allocated randomly to the pneumatic leg compression group (n = 50) or control (n = 50). In the intervention group, pneumatic leg compression was initiated before induction of anaesthesia. In the control group, pneumatic leg compression was initiated 20 min after anaesthesia induction. The primary outcome was the incidence of post-induction hypotension in these groups. Post-induction hypotension was defined as systolic blood pressure < 90 mmHg during the first 20 min after induction. Haemodynamic variables and area under the curve of post-induction systolic blood pressure over time were assessed. Complications associated with pneumatic leg compression were recorded, including: peripheral neuropathy; compartment syndrome; extensive bullae beneath the leg sleeves; and pulmonary thromboembolism. The incidence of post-induction hypotension decreased in the pneumatic leg compression group compared with that in the control group; 5 (10%) vs. 29 (58%), respectively, p < 0.001. In the pneumatic leg compression group, the lowest systolic, diastolic and mean blood pressures 20 min after induction of anaesthesia were significantly greater than the control group. Pneumatic leg compression resulted in an increased area under the curve of systolic blood pressure in the first 20 min after induction, p = 0.001. There were no pneumatic leg compression-related complications. Pneumatic leg compression reduced post-induction hypotension in elderly patients undergoing robot-assisted laparoscopic prostatectomy, suggesting that it is an effective and safe intervention to prevent post-induction hypotension among elderly patients undergoing general anaesthesia. 相似文献
10.
2022新年伊始, 《中华消化杂志》总编辑代表杂志编委会和编辑部全体成员向支持、关心本刊发展的各界人士、广大读者和作者致以诚挚的祝福和衷心的感谢。2021年, 《中华消化杂志》创刊40周年纪念册顺利出版和《中华消化杂志》创刊40周年庆祝会顺利召开, 为杂志40周年画上了圆满句号。2022年, 《中华消化杂志》将继续秉承前辈们的优良传统, 开拓进取, 在传承中发展、继承中创新, 进一步提高期刊学术水平和影响力。 相似文献